Corticotropin-releasing hormone and the blood-brain-barrier

Front Biosci
01 January 2007
https://pubmed.ncbi.nlm.nih.gov/17127408/

Relationship of human herpes virus 6 and multiple sclerosis: A systematic review and meta-analysis

J Cell Physiol
April 2018
https://pubmed.ncbi.nlm.nih.gov/28631829/

Recovery from Chronic Demyelination by Thyroid Hormone Therapy: Myelinogenesis Induction and Assessment by Diffusion Tensor Magnetic Resonance Imaging

J Neurosci
24 December 2008
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844750/

What Could Be a Primary Cause of Multiple Sclerosis: Is It an Autoimmunity Triggered by Chronic Protozoan Infection?

Journal of neuroinfectious diseases
2013
https://www.semanticscholar.org/paper/What-Could-Be-a-Primary-Cause-of-Multiple-Is-It-an-Simka/da3bebf4d4f100c49b4aad382a14781e268443be

Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis

J Microbiol Immunol Infect
August 2011
https://pubmed.ncbi.nlm.nih.gov/21524958/

Nematode filarial Worms in cerebrospinal fluid of a Multiple Sclerosis Patient at Autopsy

19 January 2016
https://f1000research.com/posters/5-79

Central nervous system infectious diseases mimicking multiple sclerosis: recognizing distinguishable features using MRI

Arq Neuropsiquiatr
September 2013
https://pubmed.ncbi.nlm.nih.gov/24141516/

Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial

Support Care Cancer
10 Jan 2022
https://pubmed.ncbi.nlm.nih.gov/35001215/

Paul Battle PA-C - Potential Applications for LDN (2013 Conference) (LDN, low dose naltrexone)